threonine has been researched along with Parkinsonian Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bräuning, B; Groll, M; Itzen, A; Kachariya, N; Lai, YC; Mulholland, K; Muqit, MMK; Sattler, M; Singh, PK; Toth, R; Vieweg, S; Volpi, I | 1 |
| Bisceglio, G; Farrer, MJ; Hope, AD; Hulihan, M; Kachergus, J; Lincoln, S; Myhre, R | 1 |
| Rodacker, V; Toustrup-Jensen, M; Vilsen, B | 1 |
| Agid, Y; Anheim, M; Brice, A; Charles, P; Czernecki, V; Dürr, A; Lesage, S; Lohmann, E; Pollak, P; Schüpbach, M; Welter, ML; Worbe, Y; Yaici, S | 1 |
| Gollamudi, S; Jeon, BS; Kim, JY; Lee, JY; Ozelius, LJ | 1 |
| Guan, Q; He, Y; Tan, L; Zhan, Q | 1 |
| Glaser, A; Herva, R; Ingelsson, M; Jönhagen, ME; Kalimo, H; Lannfelt, L; Skoglund, L; Viitanen, M | 1 |
1 trial(s) available for threonine and Parkinsonian Disorders
| Article | Year |
|---|---|
Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.
Topics: Adult; Aged; Deep Brain Stimulation; Female; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinsonian Disorders; Protein Serine-Threonine Kinases; Retrospective Studies; Serine; Subthalamic Nucleus; Threonine | 2007 |
6 other study(ies) available for threonine and Parkinsonian Disorders
| Article | Year |
|---|---|
PINK1-dependent phosphorylation of Serine111 within the SF3 motif of Rab GTPases impairs effector interactions and LRRK2-mediated phosphorylation at Threonine72.
Topics: HEK293 Cells; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mitochondria; Parkinsonian Disorders; Phosphorylation; Protein Kinases; rab GTP-Binding Proteins; Serine; Threonine | 2020 |
Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease.
Topics: Adult; Age Factors; Alanine; alpha-Synuclein; DNA Mutational Analysis; Exons; Family Health; Female; Humans; Male; Middle Aged; Mutation; Nerve Tissue Proteins; Parkinsonian Disorders; Polymorphism, Single Nucleotide; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Synucleins; Threonine | 2004 |
Mutations Phe785Leu and Thr618Met in Na+,K+-ATPase, associated with familial rapid-onset dystonia parkinsonism, interfere with Na+ interaction by distinct mechanisms.
Topics: Animals; Chlorocebus aethiops; COS Cells; Dystonia; Genetic Predisposition to Disease; Humans; Models, Molecular; Mutation; Parkinsonian Disorders; Phenylalanine; Protein Conformation; Rats; Sodium; Sodium-Potassium-Exchanging ATPase; Threonine | 2006 |
ATP1A3 mutation in the first asian case of rapid-onset dystonia-parkinsonism.
Topics: Adult; Dystonic Disorders; Humans; Korea; Male; Methionine; Mutation; Parkinsonian Disorders; Sodium-Potassium-Exchanging ATPase; Threonine | 2007 |
Changes in the prodynorphin gene and DARPP-32 state in 6-OHDA-lesioned rats following long-term treatment with l-dopa.
Topics: Amino Acid Sequence; Animals; Basal Ganglia; Brain Chemistry; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Drug Administration Schedule; Dyskinesia, Drug-Induced; Enkephalins; Excitatory Amino Acid Antagonists; Female; Gene Expression Regulation; Levodopa; Male; Neural Pathways; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Phosphorylation; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Threonine; Time | 2007 |
The tau S305S mutation causes frontotemporal dementia with parkinsonism.
Topics: Adult; Amino Acid Substitution; Behavior; Brain; Cognition Disorders; Cysteine; Dementia; Humans; Male; Mutation; Parkinsonian Disorders; Pedigree; Personality; Phenotype; Protein Isoforms; tau Proteins; Threonine | 2008 |